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a b s t r a c t
Background. Current U.S. guidelines recommend consideration of nicotine replacement therapy (NRT) for
pregnant smokers if behavioral therapies fail, only under close supervision of a provider, and after discussion
of known risks of continued smoking and possible risks of NRT. The percentage of pregnant smokers offered
NRT by their prenatal care providers is unknown.
Purpose. The study aims to calculate the percentage of pregnant smokers offered cessation intervention and
NRT and assess independent associations between selected maternal characteristics and being offered NRT.
Methods. Data were analyzed from the 2009–2010 Pregnancy Risk Assessment Monitoring System from four
states that asked about provider practices for prenatal smoking cessation. Adjusted prevalence ratios were calculated to examine associations between being offered NRT, selected maternal characteristics, and smoking level.
Variables used in adjusted models were based on factors associated with smoking cessation during pregnancy
from prior literature and included race, age, education, insurance type, and stress.
Results. Of 3559 women who smoked 3 months before pregnancy, 77.4% (95% CI: 74.2, 80.3) of 3rd trimester
smokers and 42% (95% CI: 38.5, 46.4) of women who quit smoking during pregnancy were offered at least one
cessation method. Among smokers, 19.1% (95% CI: 16.5, 22.1) were offered NRT and of these, almost all (94%)
were offered another cessation method.
Conclusions. One in ﬁve pregnant smokers was offered NRT. About a quarter of pregnant smokers did not receive any interventions to stop smoking. There may still be reluctance to provide NRT to pregnant women, despite known harms of continued smoking during pregnancy.
© 2015 Elsevier Inc. All rights reserved.

Introduction
Tobacco use during pregnancy is the most prevalent cause of poor infant outcomes for which effective interventions exist (US Department of
Health and Human Services [USDHHS] 2014). Prenatal smoking causes
adverse outcomes including placental abruption, preterm delivery, fetal
growth restriction, and Sudden Infant Death Syndrome (USDHHS 2014).
The last decade has seen modest declines in prevalence of prenatal
smoking; however, data from the 2010 Pregnancy Risk Assessment
Monitoring System (PRAMS) show that 23% of women with live births
smoked cigarettes before pregnancy and 11% of women smoked in the
3rd trimester of pregnancy (Tong et al., 2013).These numbers fall short
of targets set by the Healthy People 2020 initiative to reduce to 14.6% the
percentage of women entering pregnancy smoking and reduce to 1.4%
the percentage of women smoking prenatally ((USDHHS), 2013).
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The 2008 U.S. Public Health Services Guidelines recommend that clinicians ask all pregnant women about tobacco use and that pregnant
smokers be offered augmented pregnancy-tailored counseling (Fiore
et al. 2008). The American College of Obstetricians and Gynecologists
[ACOG] (2010) recommends that providers assess smoking status of
their pregnant patients and deliver a brief counseling session, such as
the 5A's (ask, advise, assess, assist, and arrange), to patients who are
willing to quit smoking, and refer them to a smoking cessation quit
line if additional support is needed. In meta-analysis, counseling interventions have been shown to improve smoking cessation during pregnancy compared to usual care (Chamberlain et al. 2013). Because
safety and efﬁcacy of nicotine replacement therapy (NRT) during pregnancy have not been established, ACOG (2010) states that NRT only be
used under the close supervision of a provider after all known risks of
continued smoking and possible risks of NRT have been discussed, and
only after behavioral therapy fails to achieve cessation in patients with
a “clear resolve to quit smoking”. Bupropion and varenicline are U.S.
Food and Drug Administration (FDA)-approved medications for
smoking cessation in general populations; however, no trials have
assessed their safety and use for cessation during pregnancy. Given
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that both drugs carry federally mandated product warnings about the
risk of psychiatric symptoms and suicide associated with their use,
ACOG (2010) recommends that pregnant patients who choose to use
these medications be closely supervised.
Several studies have summarized providers' self-reported practices
of delivering smoking cessation interventions (Hartmann et al. 2007,
Oncken et al. 2000, Jordan, Dake & Price 2006, Association of American
Medical Colleges 2012), but fewer studies exist on pregnant women's
report of being offered interventions by their provider, including NRT.
In a trial using telephone counseling, researchers found that 29% of
pregnant smokers reported discussing a cessation medication, including
NRT, with their obstetric providers, and 10% reported using a medication during pregnancy (Rigotti et al. 2008). Using data from a representative sample of women with a live birth in New Jersey during 2004 to
2005, another study found that almost all women reported being
asked by their provider if they smoked, 57% reported their provider
had spent time with them discussing how to quit, 12% reported using
some type of cessation method (such as self-help materials, counseling,
medications, classes, or quit lines), and 4% reported using medications
(Tong et al. 2008). However, that study did not assess whether the provider had offered cessation medications such as NRT, bupropion, or
varenicline to women, nor did it ask if the women were referred to a
smoking cessation quit line.
Also, disparities in providing smoking cessation have been documented for the general population of smokers. Non-Hispanic Black
smokers are less likely to utilize evidence-based cessation treatments
(CDC 2011). Though scant, there has been mixed evidence regarding
disparities in the receipt of smoking cessation interventions in prenatal
care among pregnant smokers. Some studies have noted that Black pregnant women were more likely to receive provider counseling on interventions for smoking cessation (Petitti et al. 1991, Tran et al. 2010)
while another noted that Black women were less likely to receive
provider advice about smoking cessation (Kogan et al., 1994). Thus, exploring associations between provider assistance and maternal characteristics among pregnant smokers may help to information cessation efforts.
The objectives of this study were to determine the types of smoking
cessation methods being offered by prenatal care providers in a
population-based sample of pregnant smokers and to examine associations between maternal characteristics and providers' recommendation
of NRT.
Methods
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Measures
Smoking status was deﬁned using three questions from the
PRAMS survey. First, all respondents were asked if they had smoked
any cigarettes in the past 2 years. Women who responded ‘Yes’ were
asked to specify how many cigarettes they smoked per day on average in the three months before pregnancy, and in the last 3 months of
pregnancy. The response categories for both time periods included:
no cigarettes, less than 1, 1 to 5, 6 to 10, 11 to 20 and 41 or more cigarettes. Smokers were categorized as women who reported smoking
any cigarettes in the 3 months before pregnancy and reported
smoking any (includes b 1 cigarette/day) cigarettes during the last
3 months of pregnancy. Quitters were deﬁned as women who reported smoking in the 3 months before pregnancy and did not
smoke any cigarettes in the last 3 months of pregnancy. As the
study is descriptive, the use of cessation interventions should be
interpreted with caution. Some quitters may have quit upon learning
of pregnancy and/or prior to prenatal care.
Respondents who reported smoking in the 3 months before pregnancy were asked about smoking cessation methods or services offered
during prenatal care by their provider (Table 2). Cessation methods
were further grouped into any cessation method (a, b, c, d, e, f, g, h, i,
j, or k), provider counseling (a, b, c, or f); self-help materials only (d), referral to counseling or quit line (e or g), and recommended or prescribed any NRT (h, i, or j). Timing of offer of any cessation method is
not reported in PRAMS.
Maternal demographics derived from the birth certiﬁcate data included maternal race/ethnicity, age, parity, education, state of residence,
and infant year of delivery. Insurance coverage during prenatal care, enrollment in the Special Supplemental Nutrition Program for Women Infants and Children (WIC) (United States Department of Agriculture
[USDA] 2013), and maternal stress were derived from the PRAMS survey. Timing of entry into prenatal care was based on birth certiﬁcate
data, or if missing on the birth certiﬁcate, was taken from the PRAMS
survey. Maternal stress, which has known associations with smoking
and decreased likelihood of cessation (Hauge, Torgersen & Vollrath
2012), was based on responses to a list of 13 negative life events included in PRAMS, such as, ‘I had a lot of bills I couldn't pay,’ and ‘I lost my job
even though I wanted to go on working,’ and was categorized into no, 1
to 2, or 3 or more stressors.

Analytic approach

Study population and data source
PRAMS is a population-based surveillance system which collects data on selected maternal behaviors and experiences before, during, and after pregnancy
among women with a recent live delivery. In 2013, PRAMS included data for 41
sites: 40 states and New York City. This study analyzed 2009–2010 data from
the four states (Illinois, Missouri, Oregon, and West Virginia) that collected information on prenatal care provider assistance for smoking cessation and
achieved a weighted annual response rate of at least 65%. Responses are weighted to account for non-response, non-coverage and oversampling, to be representative of each state's entire population of women delivering a live infant.
Detailed methodology is described elsewhere (Shulman, Gilbert & Lansky,
2006). The Centers for Disease Control and Prevention Institutional Review
Board approved the PRAMS protocol; all sites approved the study plan.
In the four states during 2009–2010, a total of 10,958 women participated in
the survey. Women who had no prenatal care (n = 80) were excluded, as it was
assumed providers would not have had an opportunity to offer them smoking
cessation services (Fig. 1). Women with missing information on entry into prenatal care (n = 12), smoking status before and during pregnancy (n = 189),
and those who were nonsmokers (n = 7118) were also excluded. The ﬁnal sample included 2069 (13.9%) pregnant women who reported smoking in the last 3
months of pregnancy. Women who quit smoking by the last trimester (n =
1490) were analyzed separately from women who smoked in the last 3 months
of pregnancy to examine differences in receipt of provider assistance with
smoking cessation between the two groups.

PRAMS data used in this analysis were weighted to adjust for survey
design and non-response, and estimates are representative of women
with live births in each participating state. SUDAAN (version 11) was
used for analyses to account for the complex survey design.
Prevalence estimates and 95% conﬁdence intervals (CIs) of receipt of
any or speciﬁc types of prenatal care provider assistance with smoking
cessation and offer of NRT for smoking cessation were calculated overall
and by demographic characteristics. Chi-square tests (p b 0.05) were
used to test for differences in percentages by maternal characteristics.
Multivariable analyses were performed to examine demographic and
service use variables associated with receipt of provider assistance for
smoking cessation and offer of NRT. Adjustments in the analyses were
made for race, age, parity, marital status, education, insurance type,
WIC status, smoking intensity, and maternal stress. Covariates were included in the multivariable models based on factors associated with
smoking cessation during pregnancy from prior literature. (Tong et al.
2008; Vaz et al. 2014; Tran et al. 2010; Adams et al. 2008; Kogan et al.
1994; Adams et al. 1992). Infant year of birth was included in the
models to control for differences over time. As PRAMS is a crosssectional survey, unadjusted and adjusted prevalence ratios (PR) and
95% CIs were calculated using logistic regression, as described by
Bieler and colleagues (2010).
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Women with a live birth in 2009-2010
(IL, MO, OR, WV)
N=10,958

Had any prenatal care
N=10,866

# Had

no prenatal care
N= 80

Did not smoke before
pregnancy
N=7,118

Smoked before
pregnancy
N=3,559

* Missing
data
N=12

~Missing
data
N=189

Sub sample
N=10,677

Smoked during the last 3
months of pregnancy
N=2,069

Smokers
N=2,069
(13.9%)

Did not smoke during the last
3 months of pregnancy
N=1,490

Quitters
N=1,490
(14.4%)

^ Non

Smokers
N=7,118
(71.6%)

Excluded
N=7,399

Fig. 1. Diagram of case selection criteria for this study. Exclusions: #Women who had no prenatal care on birth certiﬁcate and PRAMS survey. *Women with missing data on prenatal care
on birth certiﬁcate or PRAMS survey. ~Women with missing data on smoking before or during pregnancy. ^Women who reported no cigarette use at any time 2 years before pregnancy.

Results
Overall, 13.9% of women reported smoking in the last 3 months of
pregnancy, and 14.4% had quit by the 3rd trimester of pregnancy.
Smokers tended to be age 20–29 (66.4%), non-Hispanic white (83.6%),
unmarried (66.7%), have high school education or less (43.4% and
29.7%), enrolled in WIC (72.8%), insured by Medicaid (83.1%), reported
3 or more stressors (59.2%), smoke N20 cigarettes before pregnancy
(13.6%) and lived in West Virginia (17.8%). Quitters had similar characteristics compared to smokers, with the exception of being primiparous
(53.8%), and lighter smokers (b1–5 cigarettes per day) in the 3 month
before pregnancy (52.4%) (Table 1).
Overall, 77.4% of smokers and 42.4% of quitters reported that a prenatal care provider offered at least one cessation method to help them
quit (Table 2). Prevalence of receipt of almost all cessation methods
was statistically higher for smokers than quitters, with the exception
of receipt of nicotine nasal spray or nicotine inhaler. The method most
frequently offered was provider counseling on how to quit for both
smokers (59.2%) and quitters (31.9%). About one in four smokers
(22.6%) and over half of quitters (57.6%) did not report receiving any
smoking cessation method.
The overall prevalence of recommendation of any NRT method was
almost three times greater among smokers (19.1%) than quitters (7.1%).
Nicotine patch and gum were the most prevalent NRT formulations recommended compared to spray or inhaler. Of smokers offered NRT (n =
432), almost all (93.8%) reported also being offered other behavioral
methods (data not shown).
Among smokers, prevalence of receipt of provider assistance was
highest among women who were 20 to 29 years old, were primiparous,

were enrolled in Medicaid, and who participated in WIC (Table 3). In adjusted analyses, WIC status (aPR = 1.16, 95% CI: 1.03, 1.32) and 3rd trimester entry into prenatal care (aPR = 1.20, 95% CI: 1.06, 1.36)
remained signiﬁcantly associated with receipt of provider assistance.
Among quitters, receipt of provider assistance was highest among
women less than age 20, with a high school education or less, unmarried, and enrolled in Medicaid and WIC. After adjusting for covariates,
age b20 (aPR = 1.44, 95% CI: 1.01, 2.04), and smoking 6–10, 11–20
and N 20 cigarettes per day before pregnancy (aPR = 1.37, 95% CI:
1.08, 1.73; aPR = 1.68, 95% CI: 1.33, 2.12 and aPR = 1.60, 95% CI: 1.05,
2.45 respectively) remained signiﬁcantly associated with provider assistance (Table 3).
Prevalence of receipt of a recommendation or prescription for NRT
for smoking cessation, was highest among pregnant smokers with a
high school education or less, entered prenatal care in 2nd trimester,
who smoked 20 + cigarettes before or during pregnancy, and who
lived in Oregon (Table 4). In the adjusted analysis, the strongest predictor for receipt of NRT among smokers was smoking N 20 cigarettes per
day during pregnancy (aPR = 2.57, 95% CI: 1.49, 4.43). Other predictors
were: having a high school education (aPR = 1.77, 95% CI: 1.15, 2.71) or
less (aPR = 1.64, 95% CI: 1.03, 2.63), smoking 6–10 or 11–20 cigarettes
per day during pregnancy (aPR = 1.68, 95% CI: 1.15, 2.45 and aPR =
2.20, 95% CI: 1.38, 3.50 respectively) and living in the state of Oregon
(aPR = 1.89, 95% CI: 1.08, 3.30). Lastly, pregnant smokers who entered
prenatal care in the 3rd trimester of pregnancy (aPR = 0.20, 95% CI:
0.07, 0.59) were less likely to be offered NRT compared with pregnant
smokers who entered prenatal care earlier in pregnancy. Among quitters, in adjusted analysis, non-Hispanic Black women (aPR = 3.07,
95% CI: 1.45, 6.52) and women who smoked 11–20 cigarettes per day
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Table 1
Maternal characteristics of pregnant women by smoking status in four states, PRAMS, 2009–2010 (unweighted N = 10,677).a
Maternal characteristics

All women
Maternal age (years)
b20
20–29
≥30
Maternal race
Non-Hispanic White
Non-Hispanic Black
Other
Parity
First
Second or later birth
Maternal education
bHigh school
High school
NHigh school
Marital status
Married
Unmarried
Trimester entry into prenatal care
1st
2nd
3rd
Insurance coverage
Medicaid or public
Private/HMOe
WIC programf enrollee during pregnancy
Yes
No
Maternal stressg
0
1–2
3 or more
Average number of cigarettes smoked per day in the 3 months before pregnancy
b1–5
6–10
11–20
N20
Average number of cigarettes smoked per day during last 3 months of pregnancy
b1–5
6–10
11–20
N20
State
IL
MO
OR
WV
Infant year of birth
2009
2010

Nonsmokersb
%, unweighted
n = 7118
(95% CI)

Smoked 3 months before pregnancy

p-Value⁎

Smokersc
%, unweighted n = 2069
(95% CI)

Quittersd
%, unweighted n = 1490
(95% CI)

71.6 (70.4, 72.8)

13.9 (13.1, 14.9)

14.4 (13.5, 15.4)

9.1 (8.2, 10.1)
48.5 (46.8, 50.1)
42.4 (40.8, 44.1)

12.5 (10.3, 15.0)
66.4 (63.0, 69.7)
21.1 (18.3, 24.1)

14.1 (11.8, 16.9)
62.8 (59.2, 66.3)
23.0 (20.1, 26.3)

b0.001

62.9 (61.3, 64.4)
11.8 (10.6, 13.1)
25.3 (24.0, 26.7)

83.6 (80.6, 86.2)
9.5 (7.4, 12.2)
6.9 (5.4, 8.8)

78.3 (74.9, 81.2)
9.7 (7.5, 12.5)
12.0 (9.9, 14.5)

b0.001

41.2 (39.6, 42.8)
58.8 (57.2, 60.4)

35.2 (31.9, 38.6)
64.8 (61.4, 68.0)

53.8 (50.2, 57.4)
46.2 (42.6, 49.8)

b0.001

16.2 (15.0, 17.4)
22.4 (21.1, 23.9)
61.4 (59.8, 63.0)

29.7 (26.6, 32.9)
43.4 (40.0, 46.9)
26.9 (23.9, 30.1)

19.7 (16.9, 22.8)
31.6 (28.3, 35.1)
48.7 (45.0, 52.3)

b0.001

68.9 (67.3, 70.4)
31.0 (29.5, 32.7)

33.3 (30.2, 36.6)
66.7 (63.4, 69.8)

44.6 (41.1, 48.2)
55.4 (51.8, 58.9)

b0.001

87.2 (86.0, 88.2)
11.1 (10.1, 12.2)
1.7 (1.3, 2.2)

77.9 (74.9, 80.7)
19.5 (16.9, 22.5)
2.5 (1.6, 4.0)

81.9 (78.8, 84.6)
15.5 (13.0, 18.4)
2.6 (1.6, 4.3)

b0.001

45.9 (44.3, 47.7)
54.0 (52.3, 55.7)

83.1 (80.2, 85.7)
16.8 (14.3, 19.8)

64.2 (60.5, 67.7)
35.8 (32.3, 39.5)

b0.001

41.9 (40.3, 43.6)
58.0 (56.4, 59.6)

72.8 (69.5, 75.9)
27.2 (24.1, 30.5)

57.7 (54.0, 61.2)
42.3 (38.7, 46.0)

33.5 (32.0, 35.1)
43.6 (41.9, 45.2)
22.9 (21.5, 24.4)

9.3 (7.6, 11.3)
31.5 (28.3, 34.8)
59.2 (55.7, 62.6)

18.1 (15.4, 21.1)
37.0 (33.5, 40.6)
44.9 (41.3, 48.6)

NA
NA
NA
NA

13.6 (11.2, 16.3)
29.9 (26.8, 33.2)
42.9 (39.5, 46.4)
13.6 (11.5, 16.1)

52.4 (48.7, 56.0)
24.8 (21.8, 27.9)
18.8 (16.1, 21.8)
4.1 (2.8, 5.8)

NA
NA
NA
NA

51.6 (48.1, 55.0)
29.5 (26.4, 32.7)
15.5 (13.2, 18.2)
3.4 (2.4, 4.7)

NA
NA
NA
NA

41.6 (40.7, 42.5)
30.8 (30.0, 31.6)
21.0 (20.4, 21.7)
6.5 (6.3, 6.8)

24.3 (21.1, 27.8)
41.9 (38.7, 45.2)
15.9 (13.8, 18.4)
17.8 (16.4, 19.4)

30.8 (27.4, 34.4)
38.7 (35.5, 42.0)
21.7 (19.3, 24.4)
8.8 (7.8, 9.9)

71.3 (70.6, 72.0)
28.7 (28.0, 29.4)

64.2 (61.3, 67.1)
35.8 (32.9, 38.7)

64.8 (61.7, 67.7)
35.2 (32.3, 38.3)

b0.001

b0.001

b0.001

b0.001

b0.001

NA = not applicable.
a
N = Unweighted sample size. Data aggregated from four PRAMS states during 2009–2010 (Illinois, Missouri, Oregon, and West Virginia); CI = conﬁdence interval.
b
Nonsmokers: Women who reported no smoking at any time in the 2 years before pregnancy.
c
Smokers: Women who reported smoking in the last 3 months of pregnancy.
d
Quitters: Women who reported smoking 3 months before pregnancy and no smoking in the last 3 months of pregnancy.
e
HMO: Health Management Organization.
f
WIC: Special Supplemental Nutrition Program for Women, Infants, and Children.
g
Maternal Stress: Number of reported negative life events.
⁎ p b 0.05 for χ2 test of independence.

(aPR = 3.51, 95% CI: 1.60, 7.71) were more likely to receive an offer of
NRT compared to their counterparts.
Discussion
One in ﬁve pregnant women who smoked in last 3 months of pregnancy reported that their prenatal care provider recommended or prescribed NRT. Almost all women who were recommended NRT also

reported receiving behavioral methods to assist with smoking cessation,
which suggests that providers who prescribe NRT are doing so in accord
with current ACOG (2005) clinical practice recommendations. Smoking
a greater number of cigarettes per day was the strongest predictor of
NRT recommendation. Also, women who lived in Oregon were more
likely to report NRT recommendation.
Obstetricians and other prenatal care providers may be reluctant to
prescribe NRT for prenatal smoking cessation because of the unknown
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Table 2
Self-reported receipt of provider assistance for smoking cessation among women who smoked 3 months before pregnancy in four states, PRAMS, 2009–2010.a
Type of provider assistanceb

a. Spend time with you discussing how to quit smoking
b. Suggest that you set a speciﬁc date to stop smoking
c. Suggest you attend a class or program to stop smoking
d. Provide you with booklets, videos, or other materials to
help you quit smoking on your own
e. Refer you to counseling for help with quitting
f. Ask if a family member or friend would support your decision to quit
g. Refer you to a national or state quit line
h. Recommend using nicotine gum
i. Recommend using a nicotine patch
j. Prescribe a nicotine nasal spray or nicotine inhaler
k. Prescribe a pill like Zyban® (also known as Wellbutrin® or Bupropion) or Chantix®
(also known as Varenicline) to help you quit
Categories of cessation assistance
Any type of assistance (a through k)
Provider counseling (a, b, c, f)
Self-help materials only (d)
Referral to counseling or quitline (e, g)
Provider counseling, self-help materials, or referral to quit line only (a, b, c, d, e, f, g)⁎⁎
Recommend or prescribe any nicotine replacement therapy (NRT) (h,i,j)

Receipt of provider assistance
N

Smokersc
% (95% CI)
N = 2069

N

Quittersd
% (95% CI)
N = 1490

p-Value⁎

1201
670
506
1018

59.2 (55.7, 62.6)
33.8 (30.5, 37.2)
22.4 (19.7, 25.5)
48.2 (44.6, 51.7)

407
248
129
306

31.9 (28.3, 35.7)
20.3 (17.3, 23.7)
9.6 (7.8, 12.1)
23.0 (19.9, 26.5)

b0.001
b0.001
b0.001
b0.001

228
629
432
329
356
72
132

11.0 (8.9, 13.5)
31.8 (28.6, 35.2)
17.4 (14.9, 20.2)
15.5 (13.1, 18.2)
15.0 (12.7, 17.5)
2.0 (1.3, 2.9)
5.9 (4.5, 7.8)

65
236
101
77
75
23
33

5.1 (3.7, 7.0)
18.1 (15.2, 21.3)
6.3 (4.7, 8.3)
5.9 (4.3, 8.0)
6.1 (4.4, 8.4
1.8 (1.0, 3.1)
2.2 (1.3, 3.6)

b0.001
b0.001
b0.001
b0.001
b0.001
NS
0.0002

1520
1370
1018
504
1505
432

77.4 (74.2, 80.3)
67.3 (63.8, 70.6)
48.2 (44.6, 51.7)
22.4 (19.5, 25.5)
75.4 (72.2, 78.4)
19.1 (16.5, 22.1)

531
482
306
124
526
91

42.4 (38.5, 46.4)
37.6 (33.87, 41.6)
23.0 (19.9, 26.5)
8.2 (6.4, 10.5)
41.6 (37.8, 45.6)
7.1 (5.3, 9.5)

b0.001
b0.001
b0.001
b0.001
b0.001
b0.001

N: unweighted sample size; CI: conﬁdence interval.
a
3559 women who reported smoking 3 months before pregnancy and who had any prenatal care. Data are aggregated from four PRAMS states during 2009–2010 (Illinois, Missouri,
Oregon, and West Virginia).
b
Type of provider assistance (a–k) was not mutually exclusive. Women could select more than one option.
c
Smokers: Women who reported smoking in the last 3 months of pregnancy.
d
Quitters: Women who reported smoking 3 months before pregnancy and no smoking in the last 3 months of pregnancy.
⁎ p b 0.05 for χ2 test of independence.
⁎⁎ Women with non-missing items for all categories.

risk–beneﬁt ratio of NRT use to the woman and fetus during pregnancy
compared with continued smoking during pregnancy. A meta-analysis
of clinical trials of NRT for prenatal smoking cessation showed that NRT
had no signiﬁcant effect on quit rates (Coleman et al. 2012); however,
low adherence to therapy makes it difﬁcult to draw ﬁrm conclusions on
its efﬁcacy (Oncken 2012). Although no statistically signiﬁcant differences
in rates of adverse birth outcomes (e.g., stillbirth, birthweight, low
birthweight) were observed between NRT or control groups (Coleman
et al. 2012). However, given that nicotine is a neuroteratogen (State of
California EPA1986), neurological outcomes have not been assessed in
NRT trials. More studies are needed to determine the safety, efﬁcacy and
effectiveness of NRT for smoking cessation during pregnancy. Use of electronic cigarettes, which may or may not have nicotine and ﬂavorings, is
becoming more prevalent among US adults and youth, and consumers
have reported using them as cessation aids (King et al.,2013; Pokhrel
et al. 2013). However, the safety, efﬁcacy and effectiveness of these products have not been established, nor are they currently regulated by the
FDA as cessation medication (USFDA, 2014). Prenatal care providers
should follow current recommendations regarding effective smoking cessation aids for pregnant smokers and utilize only those that have been
FDA-approved as cessation medications, if applicable.
Of smokers who were offered, recommended or prescribed an intervention (77.4%), two-thirds reported that their provider had a discussion with them about quitting smoking, and half reported receiving
self-help materials. The prevalence of provider counseling (67.3%) is
higher than results from previous studies (Tong et al. 2008; Chapin &
Root 2004). We also found a lack of association for many of the demographic characteristics explored (e.g., age, race/ethnicity, education, insurance status), with receipt of any provider assistance which suggests
that no apparent disparities were observed in provider assistance for
smoking cessation. This is contrasted to the general population of
smokers (CDC 2011).
Still, in our study, almost one-fourth of women who smoked in the
last 3 months of pregnancy did not report any intervention by their doctor. Because our data are based on self-report, it is possible that survey

respondents may not recall provider intervention. Despite this, providers may face a number of barriers that affect their ability to provide
smoking cessation counseling, such as a lack of awareness of guidelines,
lack of self-efﬁcacy, lack of training, lack of systems to support counseling activities, lack of materials, and perceptions that counseling takes a
long time (Chapin & Root, 2004). In addition, providers facing pregnant
patients with nicotine addiction may perceive such patients as having
no desire or interest in quitting (Hartmann et al. 2007) or as having
major life stressors that are alleviated by smoking (Grimley et al.
2001), which could also create barriers to initiating conversations
about cessation. Provider education and training on best practice approaches can help ensure all smokers who want to quit are provided effective cessation treatment (Tong et al. 2012). In addition, we found that
evidence-based interventions, such as self-help booklets and quitlines,
were under-utilized and could be promoted. Last, out-of-pocket costs
may be another barrier that, if reduced, might improve access to
smoking cessation treatment (Community Guide, 2013). The Affordable
Care Act requires states to provide effective tobacco cessation counseling and medications without cost-sharing for pregnant women enrolled
in Medicaid (Centers for Medicare & Medicaid 2013). As of 2012, Medicaid programs in all 50 states plus the District of Columbia cover all
pharmacotherapy and some form of behavioral intervention, like quit
lines or face-to-face-counseling for pregnant women (McMenamin
et al., 2012). Future research will be needed to assess whether this policy will encourage changes in provider recommendation and pregnant
women's uptake of evidence-based cessation interventions.
A small but signiﬁcant association was found between participating
in the WIC program and receipt of smoking cessation methods may be
explained at least in part by its strongly recommended programmatic
and prevention strategies to assist low-income pregnant, postpartum
women, and their infants, including the provision of screening and
referrals to other health and social services (US Department of
Agriculture [USDA] 2013). For example, in Missouri, WIC participants
are provided with anti-smoking and cessation information along with
other client intake materials (Missouri Department of Health and
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Table 3
Receipt of provider assistance for smoking cessation by maternal characteristics of women who smoked 3 months before pregnancy in four states, PRAMS, 2009–2010.a
Smokersb
N = 2069
Maternal characteristics
Maternal age⁎,# (years)
b20
20–29
≥30
Maternal race
Non-Hispanic White
Non-Hispanic Black
Other
Parity⁎
First
Second or later birth
Maternal education#
bHigh school
High school
NHigh school
Marital status#
Married
Other
Trimester entry into prenatal care
1st
2nd
3rd
Insurance coverage⁎#
Medicaid or public
Private/HMOf
WIC programg enrollee during pregnancy⁎#
Yes
No
Maternal stressh
0
1–2
3 or more
Average number of cigarettes smoked per day in the
3 months before pregnancy
b1–5
6–10
11–20
N20
Average number of cigarettes smoked per day during
last 3 months of pregnancy
b1–5
6–10
11–20
N20
State
Illinois
Missouri
Oregon
West Virginia
Infant year of birth⁎
2009
2010

Quittersc
N = 1490

Receipt of provider assistance Adjusted prevalence ratiod Receipt of provider assistance Adjusted prevalence ratioe
(95% CI)
% (95% CI)
(95% CI)
% (95% CI)
79.6 (69.7, 86.8)
80.2 (76.7, 83.4)
69.4 (61.4, 76.3)

1.04 (0.88, 1.24)
1.08 (0.97, 1.20)
Ref

61.0 (50.6, 70.5)
41.7 (36.9, 46.7)
32.5 (24.8, 41.2)

1.44 (1.01 2.04)
0.99 (0.75, 1.31)
Ref

77.1 (73.6, 80.2)
84.0 (72.8, 91.1)
79.4 (66.5, 88.2)

Ref
1.09 (0.97, 1.22)
0.97 (0.81, 1.15)

41.3 (37.0, 45.7)
51.5 (36.9, 65.8)
43.3 (32.6, 54.6)

Ref
1.09 (0.75, 1.58)
0.90 (0.66, 1.23)

81.8 (76.8, 85.9)
75.8/ (71.8, 79.4)

1.08 (0.99, 1.17)
Ref

42.0 (36.7, 47.5)
43.5 (37.8, 49.3)

0.88 (0.72, 1.07)
Ref

78.6 (72.9, 83.4)
79.5 (74.6, 83.6)
74.9 (68.5, 80.4)

0.98 (0.88, 1.10)
1.00 (0.91, 1.10)
Ref

55.5 (46.5, 64.1)
46.8 (39.9, 53.7)
33.5 (28.3, 39.3)

1.24 (0.93, 1.65)
1.10 (0.86, 1.42)
Ref

74.4 (68.4, 79.4)
79.6 (75.8, 82.9)

Ref
0.98 (0.90, 1.07)

34.4 (29.2, 39.9)
49.5 (44.0, 55.1)

Ref
1.12 (0.90, 1.41)

77.4 (73.9, 80.6)
78.6 (71.4, 84.5)
86.9 (69.3, 95.1)

Ref
1.02 (0.93, 1.13)
1.20 (1.06, 1.36)

41.4 (37.2, 45.8)
49.8 (39.3, 60.3)
43.6 (20.2, 70.2)

Ref
1.01 (0.77, 1.32)
0.82 (0.38, 1.78)

80.3 (77.1, 83.2)
67.3 (57.9, 75.5)

1.07 (0.92, 1.25)
Ref

48.7 (43.6, 53.8)
31.5 (25.5, 38.2)

1.07 (0.79, 1.45)
Ref

81.2 (77.9, 84.1)
68.6 (61.3, 75.0)

1.16 (1.03, 1.32)
Ref

49.7 (44.5, 54.8)
32.5 (26.8, 38.7)

1.21 (0.92, 1.60)
Ref

75.8 (66.1, 83.4)
77.9 (72.2, 82.8)
77.8 (73.5, 81.6)

Ref
1.02 (0.91, 1.15)
0.98 (0.87, 1.10)

33.1 (24.6, 42.8)
43.8 (37.5, 50.3)
44.5 (38.6, 50.6)

Ref
1.17 (0.86, 1.58)
1.04 (0.76, 1.43)

77.9 (68.0, 84.5)
76.4 (70.3, 81.5)
77.7 (72.9, 81.9)
81.9 (73.7, 87.9)

Ref
1.01 (0.89, 1.15)
1.02 (0.89, 1.16)
1.09 (0.94, 1.28)

33.8 (28.4, 39.6)
49.0 (41.6, 56.5)
52.2 (43.6, 60.7)
54.7 (35.8, 72.4)

Ref
1.37 (1.08, 1.73)
1.68 (1.33, 2.12)
1.60 (1.05, 2.45)

77.0 (72.4, 81.0)
81.3 (75.5, 86.0)
76.8 (69.2, 83.0)
65.1 (46.0, 80.3)

Ref
1.06 (0.96, 1.16)
1.06 (0.96, 1.17)
0.99 (0.82, 1.19)

NA
NA
NA
NA

NA
NA
NA
NA

79.0 (70.4, 85.4)
76.5 (71.4, 80.9)
81.4 (73.6, 87.2)
76.4 (72.8, 79.8)

1.07 (0.95, 1.19)
Ref
1.07 (0.96, 1.19)
0.97 (0.90, 1.05)

38.6 (30.3, 47.7)
45.6 (39.6, 51.7)
43.2 (35.8, 50.9)
41.0 (34.8, 47.6)

Ref
1.22 (0.91, 1.64)
1.20 (0.88, 1.64)
1.01 (0.74, 1.39)

78.2 (74.0, 81.9)
77.3 (72.7, 81.3)

1.01 (0.93, 1.08)
Ref

43.1 (37.9, 48.5)
42.0 (36.5, 47.6)

1.15 (0.93, 1.41)
Ref

CI: conﬁdence interval.
a
3559 women who reported smoked 3 months before pregnancy and who received any prenatal care. Data aggregated from four PRAMS states during 2009–2010 (Illinois, Missouri,
Oregon, and West Virginia).
b
Smokers: Women who reported smoking in the last 3 months of pregnancy.
c
Quitters: Women who reported smoking 3 months before pregnancy and no smoking in the last 3 months of pregnancy.
d
From a sample of 2069 smokers, a total of 1813 women were included in this model after exclusion of women with missing information for any covariates.
e
From a sample of 1490 quitters, a total of 1112 women were included in this model after exclusion of women with missing information for any covariates.
f
HMO: health management organization.
g
WIC: Special Supplemental Nutrition Program for Women, Infants, and Children.
h
Maternal stress: number of reported negative life events.
⁎ Signiﬁcant at p b 0.05 using chi-square test to compare characteristics of smokers who received provider assistance with smoking cessation and those who did not receive assistance.
#
Signiﬁcant at p b 0.05 using chi-square test to compare characteristics of quitters who received provider assistance with smoking cessation and those who did not receive assistance.

Senior Services 2013). In Oregon, all prenatal WIC applicants are
screened for current smoking status at the time of their initial enrollment. Referrals are routinely made to the state quit line and local
smoking cessation programs, quit line posters are displayed in clinics,

and written materials on smoking cessation are available to participants
(S. Greathouse, Oregon WIC Program, personal communication, April
15, 2013). These results highlight the critical importance of an integrated effort among service providers for a continuum of care during
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Table 4
Self-reported receipt of nicotine replacement therapy (NRT) for smoking cessation by maternal characteristics of women who smoked 3 months before pregnancy in four states, PRAMS,
2009–2010.a
Smokersb
Maternal characteristics
Maternal age (years)
b20
20–29
≥30
Maternal race
Non-Hispanic White
Non-Hispanic Black
Other
Parity
First birth
Second or later birth
Maternal education⁎
bHigh school
High school
NHigh school
Marital status
Married
Other
Trimester entry into prenatal care⁎
1st
2nd
3rd
Insurance coverage
Medicaid or public
Private/HMOf
Enrolled in WIC programg during pregnancy
Yes
No
Maternal stressh
0
1–2
3 or more
Average number of cigarettes smoked per day 3 months before pregnancy⁎
b1–5
6–10
11–20
N20
Average number of cigarettes smoked per day during last 3 months of pregnancy⁎
b1–5
6–10
11–20
N20
State⁎
Illinois
Missouri
Oregon
West Virginia
Infant year of birth⁎
2009
2010

Offered NRT
% (95% CI)

Quittersc
Adjusted prevalence ratiod Offered NRT
(95% CI)
% (95% CI)

Adjusted prevalence ratioe
(95% CI)

23.7 (15.8, 34.1) 1.20 (0.67, 2.14)
18.6 (15.5, 22.1) 0.92 (0.63, 1.35)
21.1 (15.6, 27.8) Ref

8.5 (4.3, 16.2)
7.0 (4.9, 10.0)
6.3 (2.9, 13.3)

1.90 (0.65, 5.53)
0.94 (0.39, 2.26)
Ref

19.0 (16.2, 22.2) Ref
24.2 (14.8, 37.0) 1.54 (0.97, 2.43)
13.2 (7.8, 22.1)
0.78 (0.47, 1.31)

6.1 (4.4, 8.6)
Ref
16.7 (8.1, 31.1) 3.07 (1.45, 6.52)
5.7 (2.3, 13.0) 1.36 (0.51, 3.63)

20.0 (15.6, 25.3) 1.16 (0.81, 1.66)
18.4 (15.4, 21.9 Ref

7.0 (4.5, 10.6)
7.3 (4.9, 10.7)

Ref
1.27 (0.72, 2.26)

22.9 (17.9, 28.8) 1.64 (1.03, 2.63)
21.7 (17.6, 26.5) 1.77 (1.15, 2.71)
11.7 (8.2, 16.5)
Ref

9.5 (5.5, 15.8)
5.2 (3.1, 8.7)
7.6 (4.2, 10.3)

1.99 (0.92, 4.31)
Ref
1.62 (0.78, 3.39)

18.8 (14.8, 23.6) Ref
19.3 (16.1, 23.1) 0.82 (0.61, 1.12)

6.8 (4.4, 10.5)
7.3 (4.9, 10.8)

Ref
0.63 (0.29, 1.39)

18.5 (15.7, 21.7) Ref
22.9 (16.7, 30.7) 1.12 (0.81, 1.56)
6.9 (2.6, 17.0)
0.20 (0.07, 0.59)

7.1 (5.2, 9.7)
7.6 (3.2, 17.0)
4.4 (1.2, 16.2)

Ref
0.74 (0.35, 1.54)
0.52 (0.12, 2.20)

20.5 (17.5, 23.8) 1.25 (0.74, 2.10)
13.8 (8.8, 21.1)
Ref

8.0 (5.6, 11.4)
5.4 (3.0, 9.5)

1.03 (0.50, 2.10)
Ref

19.4 (16.4, 22.7) 0.85 (0.60, 1.20)
18.5 (13.5, 24.8) Ref

7.8 (5.4, 11.2)
6.0 (3.6, 9.7)

1.25 (0.67, 2.36)
Ref

20.4 (13.1, 30.4) Ref
18.0 (13.9, 23.0) 0.87 (0.53, 1.43)
19.8 (16.2, 23.9) 0.92 (0.56, 1.51)

5.9 (2.7, 12.3)
6.0 (3.5, 10.1)
8.5 (5.6, 12.6)

Ref
1.08 (0.43, 2.71)
1.24 (0.53, 2.89)

16.9 (10.4, 26.4)
18.0 (13.8, 23.2)
17.1 (13.4, 21.4)
30.5 (22.6, 39.7)

Ref
1.01 (0.63, 1.62)
0.78 (0.45, 1.33)
1.35 (0.74, 2.46)

4.9 (2.7, 8.6)
5.9 (3.4, 9.9)
11.9 (7.3, 18.7)
15.0 (5.7, 34.0)

Ref
1.48 (0.66 3.29)
3.51 (1.60, 7.71)
1.96 (0.58, 6.62)

14.6 (11.4, 18.4)
21.8 (17.0, 27.4)
26.0 (18.8, 34.8)
34.1 (20.5, 50.9)

Ref
1.68 (1.15, 2.45)
2.20 (1.38, 3.50)
2.57 (1.49, 4.43)

NA
NA
NA
NA

NA
NA
NA
NA

11.8 (7.0, 19.2)
20.6 (16.5, 25.4)
25.3 (18.5, 33.6)
20.4 (17.4, 23.9)

Ref
1.27 (0.73, 2.22)
1.89 (1.08, 3.30)
1.07 (0.63, 1.83)

5.2 (2.2, 11.8)
9.3 (6.3, 13.5)
5.1 (2.6, 9.6)
8.5 (5.5, 13.0)

Ref
2.24 (0.78, 6.48)
1.28 (0.35, 4.63)
1.81 (0.53, 6.19)

16.8 (13.7, 20.5) Ref
23.3 (19.1, 28.1) 1.26 (0.94, 1.68)

6.2 (4.1, 9.5)
8.5 (5.8, 12.6)

Ref
1.09 (0.59, 2.00)

CI: conﬁdence interval.
a
3559 women who reported smoking 3 months before pregnancy and who received any prenatal care. Data are aggregated from four PRAMS states during 2009–2010 (Illinois, Missouri, Oregon, and West Virginia).
b
Smokers: Women who reported smoking in the last 3 months of pregnancy.
c
Quitters: Women who reported smoking 3 months before pregnancy and no smoking in the last 3 months of pregnancy.
f
HMO: health management organization.
d
From a sample of 2069 smokers, a total of 1810 women were included in this model after exclusion of women with missing information for any covariates.
e
From a sample of 1490 quitters, a total of 1114 women were included in this model after exclusion of women with missing information for any covariates.
g
WIC: Special Supplemental Nutrition Program for Women, Infants, and Children.
h
Maternal stress: number of reported negative life events.
⁎ Signiﬁcant at p b0.05 using chi-square testing to compare characteristics of women who were offered NRT for cessation and those who were not.

pregnancy to encourage quitting, and in the postpartum period to prevent relapse.
Strengths and limitations
A major strength of this study is its large population-based sample of
pregnant women and their reports of providers' practices in providing
effective smoking cessation interventions, particularly recommendation

of NRT. Among the limitations, the self-reported survey responses, including information about smoking cessation advice and services received during prenatal care, were collected approximately 4 months
after delivery as part of a cross-sectional survey and could be subject
to recall bias. Second, many women will quit smoking when learning
of their pregnancy (Tong et al. 2008); thus, they would not need provider cessation assistance. Although we present estimates of provider assistance among quitters by the last trimester of pregnancy, it was not
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possible to discern whether women were still smoking at the time of
prenatal care. So it is likely we have overestimated the population in
need of smoking cessation among quitters. Lastly, the study ﬁndings
are not generalizable to pregnant women beyond the study states.
Conclusion
Approximately one in four pregnant women who smoked in the last
3 months of pregnancy reported their prenatal care provider did not
provide an intervention for smoking cessation. Among those who did
receive or were offered an intervention, provider counseling and provision of self-help materials were the most prevalent services. One in ﬁve
pregnant smokers reported being offered NRT for smoking cessation.
Further research is needed to understand better how physicians are
making decisions regarding NRT and which cessation methods are
most effective in helping pregnant smokers quit. Efforts are also needed
to ensure providers follow best practice approaches so that all pregnant
smokers are offered smoking cessation interventions.
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